Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms  Mariëlle.

Slides:



Advertisements
Similar presentations
Inflammatory Bowel Disease: Overview
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
How surgeons can find information online? Martin Hewitt International Journal of Surgery Volume 5, Issue 6, Pages (December 2007) DOI: /j.ijsu
Enterococcus faecalis Induces Inflammatory Bowel Disease in Interleukin-10 Knockout Mice Edward Balish, Thomas Warner The American Journal of Pathology.
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Work disability in inflammatory bowel disease
The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.
The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern Europe  Peter.
Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008  Peter Laszlo Lakatos,
IBD in the elderly population: Results from a population-based study in Western Hungary, 1977���2008  Peter Laszlo Lakatos, Gyula David, Tunde Pandur,
How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,
Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease  Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years 
Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review  Doron Boltin, Zohar Levi, Marisa Halpern,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
YouTube® and inflammatory bowel disease
Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out?  Christian Jakobsen, Vibeke Wewer, Frederikke Urne,
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years 
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series  Erik Mooiweer,
Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)  Mariam Aguas, Vicente Garrigues,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
A. J. Walsh, M. Weltman, D. Burger, S. Vivekanandarajah, S. Connor, M
Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants  T. Felekis, K.H. Katsanos, C.D. Zois,
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: A single-center cohort study  Livia.
Serum prohepcidin levels in chronic inflammatory bowel diseases
Charlotte de Bie, Angelika Kindermann, Johanna Escher 
N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard 
Fatal Colonic Perforation in a Pregnant with Behçet's Disease
Valle García-Sánchez, Eva Iglesias-Flores, Raúl González, Javier P
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years  May-Bente Bengtson, Camilla.
Public awareness of Crohn's disease and ulcerative colitis: A national survey  Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F
Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out?  Christian Jakobsen, Vibeke Wewer, Frederikke Urne,
Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases  Danuta Owczarek,
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature  Dana Duricova, Johan Burisch,
Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis  Thomas W. Lee, Michael.
Volume 147, Issue 4, Pages e7 (October 2014)
Paula Borralho, Ana Vieira, João Freitas, Paula Chaves, Jorge Soares 
Clinical trials in luminal Crohn's disease: A historical perspective
M. Chaparro, P. Martínez-Montiel, M. Van Domselaar, F. Bermejo, J. L
Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H
The usefulness of factor XIII levels in Crohn's disease
Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients  Marko Brinar, Séverine.
Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis  Niels Teich, Tobias Klugmann  Journal of.
Seth Lipka, Seymour Katz, Lev Ginzburg  Journal of Crohn's and Colitis 
Osteoporosis in inflammatory bowel disease
Pediatric pulmonary Crohn's disease: More frequent than expected
Suppurative granulomatous inflammation in the ileo-anal pouch
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Volume 131, Issue 3, Pages (September 2006)
Volume 132, Issue 2, Pages (February 2007)
Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation  Sjoerd F. Bakker,
Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.
Does active smoking really influence the course of Crohn's disease
Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease  Daniel W. Hommes, Marjolijn Duijvestein,
Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E
Surgical management of gluteal metastatic cutaneous Crohn's disease
Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis  S.D. McLaughlin, A. Culkin,
Bowel sonography in occlusive Crohn's disease
The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China  Yue Li, Li-fan Zhang, Xiao-qing.
Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors  Anilga Moradkhani, Linda.
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Volume 119, Issue 5, Pages (November 2000)
This Month in AJKD American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
This Month in AJKD American Journal of Kidney Diseases
Presentation transcript:

Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms  Mariëlle J.L. Romberg-Camps, Martine A.M. Hesselink-van de Kruijs, Leo J. Schouten, Pieter C. Dagnelie, Charles B. Limonard, Arnold D.M. Kester, Laurens P. Bos, Jelle Goedhard, Wim H.A. Hameeteman, Frank L. Wolters, Maurice G.V.M. Russel, Reinhold W. Stockbrügger  Journal of Crohn's and Colitis  Volume 3, Issue 2, Pages 115-124 (June 2009) DOI: 10.1016/j.crohns.2008.12.002 Copyright © 2009 Terms and Conditions

Figure 1 Standardized incidence rates per 100,000 person-years, 1991–2002, based on the 3-years moving average. Journal of Crohn's and Colitis 2009 3, 115-124DOI: (10.1016/j.crohns.2008.12.002) Copyright © 2009 Terms and Conditions

Figure 2 Age-specific standardized incidence rates per 100,000 person-years 1991–2002. Journal of Crohn's and Colitis 2009 3, 115-124DOI: (10.1016/j.crohns.2008.12.002) Copyright © 2009 Terms and Conditions

Figure 3 Overall variation per month in onset of symptoms for CD, UC and IC (n=1122). Journal of Crohn's and Colitis 2009 3, 115-124DOI: (10.1016/j.crohns.2008.12.002) Copyright © 2009 Terms and Conditions